NBC Securities’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
NBC Securities's ALNY Position: Q3 2026 in Review
NBC Securities opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 12 shares worth $2.96K. The stake represents ﹤0.01% of the portfolio and ranks #2215 among its holdings. This is a return to the name: NBC Securities previously reported a position in ALNY as recently as Q1 2026.
NBC Securities first reported a position in ALNY in Q3 2023 and has held it in 7 quarters since. The position peaked at $5.47K in Q3 2025. 720 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- NBC Securities held 12 shares of Alnylam Pharmaceuticals worth $2.96K as of Q3 2026.
- Alnylam Pharmaceuticals was a new NBC Securities position in Q3 2026.
- Alnylam Pharmaceuticals made up ﹤0.01% of NBC Securities's portfolio in Q3 2026, its #2215 holding.
- NBC Securities first reported a position in Alnylam Pharmaceuticals in Q3 2023 and has held it in 7 quarters since.
- NBC Securities's Alnylam Pharmaceuticals position peaked at $5.47K in Q3 2025.
- 720 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on NBC Securities's 13F filing for Q3 2026, filed 26 Oct 2026.